CYCLIN E AND GROWTH CONTROL AND TUMOROGENESIS
CYCLIN E AND GROWTH CONTROL AND TUMOROGENESIS
批准号:
2670068
负责人:
Steven I Reed
金额:
$26.25万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2003-05-31
关键词:
aminoacid analyzer antisense nucleic acid breast neoplasms carcinogenesis cell growth regulation cell proliferation cyclin dependent kinase cyclins enzyme activity flow cytometry gel mobility shift assay gene expression gene mutation genetically modified animals human tissue immunoprecipitation laboratory mouse mammary epithelium protein folding protein structure function proteolysis single strand conformation polymorphism transfection tumor suppressor proteins western blottings yeast two hybrid system
中文摘要
细胞周期蛋白E作为细胞周期蛋白依赖性激酶Cdk2的正调节因子,
是细胞周期进程的关键调节因子。 它也可以成为,当
去调节,是肿瘤发生的一个因素。 然而,无论是分子
细胞周期蛋白E刺激细胞周期进程的机制,
由此它参与肿瘤发生已经被阐明。 这
一项旨在研究细胞周期蛋白E的功能和调节的提案
在正常和肿瘤来源的人乳腺上皮细胞中,
细胞,基本原理是获得的信息可能具有
对乳腺癌预防、诊断和治疗的最终意义
癌 研究计划包括四个具体目标。 第一
通过消除细胞周期蛋白E的重要性和功能,
通过新的反义寡核苷酸技术表达细胞周期蛋白E。 的
第二个具体目标,也是使用反义寡核苷酸技术,
研究乳腺上皮细胞调节
细胞周期蛋白E相关的Cdk2激酶活性,以维持适当的
增殖反应第三个具体目标直接针对
细胞周期蛋白E失调导致恶性肿瘤的机制
转型 组织培养模型用于研究
cyclin E过表达与遗传不稳定性的关系,
而转基因小鼠模型用于直接探测
细胞周期蛋白E失调导致乳腺癌发生的机制。
最后,第四个具体目标是调查是否
细胞周期蛋白E蛋白水解或成熟的失调在细胞周期蛋白
在与肿瘤发生相关的条件下E积累。 因为
试剂和技术已经可以用于执行大多数
通过这些研究,预计可以在以下方面取得迅速进展:
所有的研究方向都被提出来了。
英文摘要
Cyclin E, as a positive regulator of the cyclin-dependent kinase, Cdk2,
is a key regulator of cell cycle progression. It can also become, when
deregulated, a factor in oncogenesis. However, neither the molecular
mechanisms whereby cyclin E stimulates cell cycle progression nor those
whereby it participates in oncogenesis have been elucidated. This
proposal seeks to investigate the function and regulation of cyclin E
in both contexts in normal and tumor-derived human breast epithelial
cells, the rationale being that information gained is likely to have
eventual implications for prevention, diagnosis and therapy of breast
cancer. The research plan consists of four specific aims. The first
addresses the issue of cyclin E essentiality and function by eliminating
cyclin E expression via novel antisense oligonucleotide technology. The
second specific aim, also using antisense oligonucleotide technology,
investigates the mechanisms whereby breast epithelial cells regulate
cyclin E-associated Cdk2 kinase activity to maintain an appropiate
proliferative response. The third specific aim directly addresses the
mechanism whereby cyclin E deregulation leads to malignant
transformation. Tissue culture models are used to investigate the
relationship between cyclin E overexpression and genetic instability,
whereas a transgenic mouse model is used to directly probe the
mechanisms whereby cyclin E deregulation causes mammary carcinogenesis.
Finally, the fourth specific aim seeks to investigate whether
deregulation of cyclin E proteolysis or maturation play a role in cyclin
E accumulation under conditions associated with oncogenesis. Because
reagents and technology are already available for carrying out most of
these studies, it is anticipated that rapid progress can be achieved on
all research avenues proposed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fbw7 as a therapeutic target for treating ischemic brain injury
-
批准号:8987383
-
项目类别:
-
资助金额:$39.92万
-
财政年份:2015
-
负责人:Steven I Reed
-
依托单位:
The SCFFbw7 Substrate Cycle: phosphodegron processing and nucleolar translocation
-
批准号:8912922
-
项目类别:
-
资助金额:$39.14万
-
财政年份:2015
-
负责人:Steven I Reed
-
依托单位:
Fbw7 as a therapeutic target for treating ischemic brain injury
-
批准号:9063625
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2015
-
负责人:Steven I Reed
-
依托单位:
Fbw7 as a therapeutic target for treating ischemic brain injury
-
批准号:9247857
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2015
-
负责人:Steven I Reed
-
依托单位:
The role of Cyclin E in growth control and tumorogenesis
-
批准号:8787588
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2014
-
负责人:Steven I Reed
-
依托单位:
Fbw7 as a therapeutic target for treating Parkinson's disease
-
批准号:9084633
-
项目类别:
-
资助金额:$41.96万
-
财政年份:2014
-
负责人:Steven I Reed
-
依托单位:
Fbw7 as a therapeutic target for treating Parkinson's disease
-
批准号:8786965
-
项目类别:
-
资助金额:$43.39万
-
财政年份:2014
-
负责人:Steven I Reed
-
依托单位:
Fbw7 as a therapeutic target for treating Parkinson's disease
-
批准号:8850907
-
项目类别:
-
资助金额:$41.43万
-
财政年份:2014
-
负责人:Steven I Reed
-
依托单位:
PHOSPH OF MCM2 BY CDC7 PROMOTES PRC ASSEMBLY DURING CELL-CYCLE RE-ENTRY
-
批准号:8171473
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2010
-
负责人:Steven I Reed
-
依托单位:
The role of Cdc4/Fbw7 in Parkinson's Disease
-
批准号:8054203
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2009
-
负责人:Steven I Reed
-
依托单位:
The role of Cdc4/Fbw7 in Parkinson's Disease
-
批准号:7789612
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2009
-
负责人:Steven I Reed
-
依托单位:
The role of Cdc4/Fbw7 in Parkinson's Disease
-
批准号:7583717
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2009
-
负责人:Steven I Reed
-
依托单位:
THE S. CEREVISIAE S PHASE CHECKPOINT
-
批准号:6654501
-
项目类别:
-
资助金额:$27.78万
-
财政年份:2000
-
负责人:Steven I Reed
-
依托单位:
THE S. CEREVISIAE S PHASE CHECKPOINT
-
批准号:6377773
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2000
-
负责人:Steven I Reed
-
依托单位:
THE S. CEREVISIAE S PHASE CHECKPOINT
-
批准号:6522577
-
项目类别:
-
资助金额:$27.78万
-
财政年份:2000
-
负责人:Steven I Reed
-
依托单位:
THE S. CEREVISIAE S PHASE CHECKPOINT
-
批准号:6085936
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2000
-
负责人:Steven I Reed
-
依托单位:
CYCLIN E AND GROWTH CONTROL AND TUMOROGENESIS
-
批准号:6174238
-
项目类别:
-
资助金额:$25.68万
-
财政年份:1998
-
负责人:Steven I Reed
-
依托单位:
CYCLIN E AND GROWTH CONTROL AND TUMOROGENESIS
-
批准号:6513261
-
项目类别:
-
资助金额:$28.6万
-
财政年份:1998
-
负责人:Steven I Reed
-
依托单位:
The role of Cyclin E in growth control and tumorogenesis
-
批准号:7647841
-
项目类别:
-
资助金额:$40.47万
-
财政年份:1998
-
负责人:Steven I Reed
-
依托单位:
The role of Cyclin E in growth control and tumorogenesis
-
批准号:6898273
-
项目类别:
-
资助金额:$35.29万
-
财政年份:1998
-
负责人:Steven I Reed
-
依托单位:
海外基金